2CZ2
| Crystal structure of glutathione transferase zeta 1-1 (maleylacetoacetate isomerase) from Mus musculus (form-1 crystal) | Descriptor: | GLUTATHIONE, GLYCEROL, Maleylacetoacetate isomerase | Authors: | Mizohata, E, Morita, S, Kinoshita, Y, Nagano, K, Uda, H, Uchikubo, T, Shirouzu, M, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | Deposit date: | 2005-07-10 | Release date: | 2006-01-10 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.4 Å) | Cite: | Crystal structure of glutathione transferase zeta 1-1 (maleylacetoacetate isomerase) from Mus musculus (form-1 crystal) To be Published
|
|
2CX0
| Crystal structure of a PUA domain (APE0525) from the Aeropyrum pernix K1 (sulfate complex) | Descriptor: | SULFATE ION, hypothetical protein APE0525 | Authors: | Mizohata, E, Morita, S, Nagano, K, Uda, H, Terada, T, Shirouzu, M, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | Deposit date: | 2005-06-27 | Release date: | 2005-12-27 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crystal structure of a PUA domain (APE0525) from the Aeropyrum pernix K1 (sulfate complex) To be Published
|
|
6QBL
| |
6QBK
| |
1MG8
| NMR structure of ubiquitin-like domain in murine Parkin | Descriptor: | Parkin | Authors: | Tashiro, M, Okubo, S, Shimotakahara, S, Hatanaka, H, Yasuda, H, Kainosho, M, Yokoyama, S, Shindo, H, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | Deposit date: | 2002-08-15 | Release date: | 2003-04-08 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | NMR structure of ubiquitin-like domain in PARKIN: Gene product of familial Parkinson's disease. J.Biomol.NMR, 25, 2003
|
|
1OAW
| OMEGA-AGATOXIN IVA | Descriptor: | OMEGA-AGATOXIN IVA | Authors: | Kim, J.I, Konishi, S, Iwai, H, Kohno, T, Gouda, H, Shimada, I, Sato, K, Arata, Y. | Deposit date: | 1995-06-28 | Release date: | 1995-10-15 | Last modified: | 2024-10-09 | Method: | SOLUTION NMR | Cite: | Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers. J.Mol.Biol., 250, 1995
|
|
8CIQ
| JzTx-34 toxin peptide | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-10 | Release date: | 2023-07-26 | Last modified: | 2024-10-16 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
8CJP
| JzTx-34 toxin peptide H18A mutant | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-13 | Release date: | 2023-07-26 | Last modified: | 2024-10-16 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
8CJS
| JzTx-34 toxin peptide W31A mutant | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-13 | Release date: | 2023-07-26 | Last modified: | 2024-10-23 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
8CJQ
| JzTx-34 toxin peptide E20A mutant | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-13 | Release date: | 2023-07-26 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
8CJR
| JzTx-34 toxin peptide W25A mutant | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-13 | Release date: | 2023-07-26 | Last modified: | 2024-10-09 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
8CJT
| JzTx-34 toxin peptide W33A mutant | Descriptor: | Mu-theraphotoxin-Cg1a | Authors: | Landon, C, Meudal, H. | Deposit date: | 2023-02-13 | Release date: | 2023-07-26 | Last modified: | 2024-10-23 | Method: | SOLUTION NMR | Cite: | Structure-function relationship of new peptides activating human Na v 1.1. Biomed Pharmacother, 165, 2023
|
|
1OAV
| OMEGA-AGATOXIN IVA | Descriptor: | OMEGA-AGATOXIN IVA | Authors: | Kim, J.I, Konishi, S, Iwai, H, Kohno, T, Gouda, H, Shimada, I, Sato, K, Arata, Y. | Deposit date: | 1995-06-28 | Release date: | 1995-10-15 | Last modified: | 2024-10-30 | Method: | SOLUTION NMR | Cite: | Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers. J.Mol.Biol., 250, 1995
|
|
5LCS
| |
1V66
| Solution structure of human p53 binding domain of PIAS-1 | Descriptor: | Protein inhibitor of activated STAT protein 1 | Authors: | Okubo, S, Hara, F, Tsuchida, Y, Shimotakahara, S, Suzuki, S, Hatanaka, H, Yokoyama, S, Tanaka, H, Yasuda, H, Shindo, H, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | Deposit date: | 2003-11-27 | Release date: | 2004-12-07 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers J.Biol.Chem., 279, 2004
|
|
6GGZ
| NMR structure of the scorpion toxin AmmTx3 | Descriptor: | Potassium channel toxin alpha-KTx 15.3 | Authors: | Landon, C, Meudal, H. | Deposit date: | 2018-05-04 | Release date: | 2019-01-30 | Last modified: | 2024-10-16 | Method: | SOLUTION NMR | Cite: | Synthesis by native chemical ligation and characterization of the scorpion toxin AmmTx3. Bioorg. Med. Chem., 27, 2019
|
|
1Q1Q
| Crystal structure of human pregnenolone sulfotransferase (SULT2B1a) in the presence of PAP | Descriptor: | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID, ADENOSINE-3'-5'-DIPHOSPHATE, SODIUM ION, ... | Authors: | Lee, K.A, Fuda, H, Lee, Y.C, Negishi, M, Strott, C.A, Pedersen, L.C. | Deposit date: | 2003-07-22 | Release date: | 2003-11-11 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.91 Å) | Cite: | Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone
and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical
SULT2A1 and the SULT2BG1 isoforms. J.Biol.Chem., 278, 2003
|
|
1Q1Z
| Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of PAP | Descriptor: | ADENOSINE-3'-5'-DIPHOSPHATE, SODIUM ION, sulfotransferase family, ... | Authors: | Lee, K.A, Fuda, H, Lee, Y.C, Negishi, M, Strott, C.A, Pedersen, L.C. | Deposit date: | 2003-07-23 | Release date: | 2003-11-11 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone
and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical
SULT2A1 and the SULT2BG1 isoforms. J.Biol.Chem., 278, 2003
|
|
1Q22
| Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of DHEA and PAP | Descriptor: | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE, ADENOSINE-3'-5'-DIPHOSPHATE, SODIUM ION, ... | Authors: | Lee, K.A, Fuda, H, Lee, Y.C, Negishi, M, Strott, C.A, Pedersen, L.C. | Deposit date: | 2003-07-23 | Release date: | 2003-11-11 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone
and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical
SULT2A1 and the SULT2BG1 isoforms. J.Biol.Chem., 278, 2003
|
|
1Q20
| Crystal Structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of PAP and pregnenolone | Descriptor: | (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE, ADENOSINE-3'-5'-DIPHOSPHATE, SODIUM ION, ... | Authors: | Lee, K.A, Fuda, H, Lee, Y.C, Negishi, M, Strott, C.A, Pedersen, L.C. | Deposit date: | 2003-07-23 | Release date: | 2003-11-11 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone
and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical
SULT2A1 and the SULT2BG1 isoforms. J.Biol.Chem., 278, 2003
|
|
1IWM
| Crystal Structure of the Outer Membrane Lipoprotein Receptor, LolB | Descriptor: | Outer Membrane Lipoprotein LolB, SULFATE ION | Authors: | Takeda, K, Miyatake, H, Yokota, N, Matsuyama, S, Tokuda, H, Miki, K. | Deposit date: | 2002-05-17 | Release date: | 2003-07-15 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Crystal structures of bacterial lipoprotein localization factors, LolA and LolB. Embo J., 22, 2003
|
|
1IWL
| Crystal Structure of the Lipoprotein Localization Factor, LolA | Descriptor: | MAGNESIUM ION, Outer-membrane lipoproteins carrier protein, ZINC ION | Authors: | Takeda, K, Miyatake, H, Yokota, N, Matsuyama, S, Tokuda, H, Miki, K. | Deposit date: | 2002-05-17 | Release date: | 2003-07-15 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (1.65 Å) | Cite: | Crystal structures of bacterial lipoprotein localization factors, LolA and LolB Embo J., 22, 2003
|
|
1IWN
| Crystal Structure of the Outer Membrane Lipoprotein Receptor LolB Complexed with PEGMME2000 | Descriptor: | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE, Outer Membrane Lipoprotein LolB, SULFATE ION | Authors: | Takeda, K, Miyatake, H, Yokota, N, Matsuyama, S, Tokuda, H, Miki, K. | Deposit date: | 2002-05-17 | Release date: | 2003-07-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Crystal structures of bacterial lipoprotein localization factors, LolA and LolB. Embo J., 22, 2003
|
|
1UA8
| Crystal structure of the lipoprotein localization factor, LolA | Descriptor: | Outer-membrane lipoproteins carrier protein | Authors: | Takeda, K, Miyatake, H, Yokota, N, Matsuyama, S, Tokuda, H, Miki, K. | Deposit date: | 2003-03-04 | Release date: | 2003-07-15 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Crystal structures of bacterial lipoprotein localization factors, LolA and LolB. Embo J., 22, 2003
|
|
2LRV
| |